v3.25.1
Organization - Schedule of Major Subsidiaries Consolidated (Details)
12 Months Ended
Dec. 31, 2024
Aptorum Therapeutics Limited (“ATL”) [Member]  
Schedule of Major Subsidiaries Consolidated [Line Items]  
Incorporation date Jun. 30, 2016
Ownership 100.00%
Place of incorporation Cayman Islands
Principle activities Research and development of life science and biopharmaceutical products
APTUS MANAGEMENT LIMITED [Member]  
Schedule of Major Subsidiaries Consolidated [Line Items]  
Incorporation date May 16, 2017
Ownership 100.00%
Place of incorporation Hong Kong
Principle activities Provision of management services to its holding company and fellow subsidiaries
Paths Innovations Limited [Member]  
Schedule of Major Subsidiaries Consolidated [Line Items]  
Incorporation date Apr. 15, 2019
Ownership 100.00%
Place of incorporation Cayman Islands
Principle activities Investment holding company
Paths Diagnostics Pte. Limited [Member]  
Schedule of Major Subsidiaries Consolidated [Line Items]  
Incorporation date Jun. 05, 2019
Ownership 75.00%
Place of incorporation Singapore
Principle activities Research and development of life science and biopharmaceutical products
Acticule Life Sciences Limited [Member]  
Schedule of Major Subsidiaries Consolidated [Line Items]  
Incorporation date Jun. 30, 2017
Ownership 80.00%
Place of incorporation Cayman Islands
Principle activities Research and development of life science and biopharmaceutical products